Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
European molecular diagnostics leader Qiagen (QGEN.US) receives a takeover offer from EQT: €46.50 per share, representing a 40.3% premium to the July share price

European molecular diagnostics leader Qiagen (QGEN.US) receives a takeover offer from EQT: €46.50 per share, representing a 40.3% premium to the July share price

智通财经智通财经2026/10/22 13:21
Show original
Smart Finance APP has learned that Qiagen (QGEN.US) announced on Thursday that it has agreed to accept an all-cash public acquisition offer from private equity firm EQT Group. The transaction values the European molecular diagnostics company at approximately 10.8 billion euros.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Locked for new tokens.
APR up to 10%. Always on, always get airdrop.
Lock now!